Unsuccessful radioiodine treatment of a non-toxic goiter: A case report

Basic and Clinical Pharmacology and Toxicology

Volumn 95, Issue 2, 2004, Pages 72-75

  Hartoft Nielsen, Marie Louise ^a   Rasmussen, Åse Krogh ^a   Friis, Esbern ^a   Blichert Toft, Mogens ^a   Buhl, Thora ^a   Hesse, Birger ^a   Feldt Rasmussen, Ulla ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE SODIUM; LIOTHYRONINE; RADIOACTIVE IODINE; TECHNETIUM 99M; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; GOITER; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; SUBTOTAL THYROIDECTOMY; THYROID ADENOMA; THYROID NODULE; THYROID SCINTISCANNING; THYROID WEIGHT; TREATMENT OUTCOME;

EID: 4744359325     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.950205.x     Document Type: Article

References (28)

1. al Suliman, N. N., N. F. Ryttov, N. Qvist, M. Blichert-Toft & H. P. Graversen: Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur. J. Surg. 1997, 163, 13-20.
2. Angusti, T., A. Codegone, R. Pellerito & A. Favero: Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism. J. Nucl. Med. 2000, 41, 1006-1009.
3. Bonnema, S. J., H. Bertelsen, J. Mortensen, P. B. Andersen, D. U. Knudsen, L. Bastholt & L. Hegedus: The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: Effect on thyroid function and size and pulmonary function. J. Clin. Endocrinol. Metab. 1999, 84, 3636-3641.
4. Bürgi, U., H. J. Peter & H. Gerber: Clinical manifestations and management of nontoxic diffuse and nodular goiter. In: Werners and Ingbar's The Thyroid. Eds.: L. E. Braverman & R. D. Utiger. Lippincott-Raven Publishers, Philadelphia, USA, 1996, pp. 896-900.
5. Council Directive 97/43/Euratom of 30 June 1997 on the health protection of individuals against the dangers of ionizing radiation in relation to medical exposure and repealing Directive 84/466/ Euratom. Official journal NO. L 180. 22-27. 1997.
6. DeGroot L. J.: Treatment of multinodular goiter by surgery. J. Endocrinol. Invest. 2001, 24, 820-822.
7. Franklyn, J. A., P. Maisonneuve, M. Sheppard, J. Betteridge & P. Boyle: Cancer Incidence and Mortality After Radioiodine Treatment for Hyperthyroidism: a Population-Based Cohort Study. Lancet 1999, 353, 2111-2115.
8. Hegedus, L. & F. N. Bennedbaek: Radioiodine for non-toxic diffuse goitre. Lancet 1997, 350, 409-110.
9. Hegedus, L., S. J. Bonnema & F. N. Bennedbaek: Management of simple nodular goiter: Current status and future perspectives. Endocr. Rev. 2003, 24, 102-132.
10. Hegedus, L., B. M. Hansen, N. Knudsen & J. M. Hansen: Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. Brit. Med. J. 1988, 297, 661-662.
11. Huysmans, D. A., A. R. Hermus, F. H. Corstens, J. O., Barentsz & P. W. Kloppenborg: Large, compressive goiters treated with radioiodine. Ann. Intern. Med. 1994, 121, 757-762.
12. Huysmans, D. A., W. A. Nieuwlaat, R. J. Erdtsieck, A. P. Schellekens, J. W. Bus, B. Bravenboer & A. R. Hermus: Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J. Clin. Endocrinol. Metab. 2000, 85, 3592-3596.
13. Kay, T. W., M. C. d'Emden, J. T. Andrews & F. I. Martin: Treatment of non-toxic multinodular goiter with radioactive iodine. Amer. J. Med. 1988, 84, 19-22.
14. Lamade, W., K. Renz, F. Willeke, E. Klar & C. Herfarth: Effect of training on the incidence of nerve damage in thyroid surgery. Brit. J. Surg. 1999, 86, 388-391.
15. Liu, Q., G. Djuricin & R. A. Prinz: Total thyroidectomy for benign thyroid disease. Surgery 1998, 123, 2-7.
16. Manders, J. M. & F. H. Corstens: Radioiodine therapy of euthyroid multinodular goitres. Eur. J. Nucl. Med. Mol. Imaging. 2002, 29 (Suppl 2), S466-S470.
17. Milazzo, G., G. L. La Rosa, R. Catalfamo, R. Vigneri & A. Belflore: Effect of TSH in human thyroid cells: Evidence for both mitogenic and antimitogenic effects. J. Cell. Biochem. 1992, 49, 231-238.
18. Miller, M. R., A. C. Pincock, G. D. Gates, R. Wilkinson & H. Skene-Smith: Upper airway obstruction due to goitre: Detection, prevalence and results of surgical management. Quart J. Med. 1990, 74, 177-188.
19. Morris, L. F., A. D. Waxman & G. D. Braunstein: Thyroid stunning. Thyroid 2003, 13, 333-340.
20. Nieuwlaat, W. A., A. R. Hermus, F. Sivro-Prndelj, F. H. Corstens & D. A. Huysmans: Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J. Clin. Endocrinol. Metab. 2001, 86, 5330-5336.
21. Nygaard, B., J. Farber, A. Veje & J. E. Hansen: Thyroid volume and function after 131I treatment of diffuse non-toxic goitre. Clin. Endocrinol. (Oxf) 1997, 46, 493-496.
22. Nygaard, B., P. Gideon, H. Dige-Petersen, N. Jespersen, K. Solling & A. Veje: Thyroid volume and morphology and urinary iodine excretion in a Danish municipality. Acta endocrinol. (Copenh.) 1993a, 129, 505-510.
23. Nygaard, B., L. Hegedus, M. Gervil, H. Hjalgrim, P. Soe-Jensen & J. M. Hansen: Radioiodine treatment of multinodular non-toxic goitre. Brit. Med. J. 1993b, 307, 828-832.
24. Peter, H. J., U. Bürgi & H. Gerber: Pathogenesis of nontoxic diffuse and nodular goiter. In: Werner and Ingbar's The Thyroid. Eds.: L. E. Braverman & R. D. Utiger. Lippincott-Raven, Philadelphia, USA, 1996, pp. 890-895.
25. Postgard, P., J. Himmelman, U. Lindencrona, N. Bhogal, D. Wiberg, G. Berg, S. Jansson, E. Nystrom, E. Forssell-Aronsson & M. Nilsson: Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells. J. Nucl. Med. 2002, 43, 828-834.
26. Ron, E., M. M. Doody, D. V. Becker, A. B. Brill, R. E. Curtis, M. B. Goldman, B. S. Harris, D. A. Hoffman, W. M. McConahey, H. R. Maxon, S. Preston-Martin, M. E. Warshauer, F. L. Wong & J. D. Boice Jr: Cancer mortality following treatment for adult hyperthyroidism. Cooperative thyrotoxicosis therapy follow-up study group. JAMA 1998, 280, 347-355.
27. Wesche, M. F., M. M. Buul, N. J. Smits & W. M. Wiersinga: Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter. Eur. J. Endocrinol. 1995, 132, 86-87.
28. Wesche, M. F., V. Tiel, P. Lips, N. J. Smits & W. M. Wiersinga: A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J. Clin. Endocrinol. Metab. 2001, 86, 998-1005.